Article
Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives
2020-11-10
Abstract excerpt
Current anticancer drug discovery and development efforts are aimed at identifying new complexes that can potently and selectively target DNA and modulate the functions of target proteins. Tin complexes, categorized as monoorganotin (RSnL 3 ), diorganotin (R 2 SnL 2 ), triorganotin (R 3 SnL), or tetraorganotin (R 4 SnL), are one of the most studied complexes in the metal‐based anticancer drug discovery and develop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f1bf39f-fd0a-514f-b307-c73412ce7fa8
- DOI
- 10.1002/aoc.6089
